TP53 and lung adenocarcinoma: In this study, SOX6 inhibits the G1/S phase transition of cell cycle by up‐regulation of p53 and p21CIPI and down‐regulation of cyclin D1 and β‐catenin expression, thereby inhibiting the proliferation, migration and invasion of lung adenocarcinoma cells.